Intellia Therapeutics, Inc. (NTLA) - Dube Michael P sold 1,864 shares
- 10/02/2026 - Sold 1,864 shares
- Price per share: $12.43
- Total shares owned after transaction: 65,022
Michael P Dube
NTLA
Intellia Therapeutics, Inc. SEC filings
Every EDGAR filing for Intellia Therapeutics, Inc. (NTLA), newest first, with AI summaries and stories.
- Ticker
- NTLA
- CIK
- 1652130
- Latest filing
- Oct 6
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 9)
Filings
4Intellia Therapeutics, Inc.NTLALIVE 144Intellia Therapeutics, Inc.NTLALIVE Intellia Therapeutics, Inc. (NTLA) - Clark Eliana files Form 144
- Filer CIK: 0001914448
- Shares to be sold: 57,750
- Date of sale: 10/05/2026
Eliana Clark
8-KIntellia Therapeutics, Inc.NTLALIVE 8-KIntellia Therapeutics, Inc.NTLALIVE 4Intellia Therapeutics, Inc.NTLALIVE John M Leonard, insider filing for NTLA
John M Leonard, reporting
144Intellia Therapeutics, Inc.NTLALIVE John M Leonard, planned sale of NTLA shares
John M Leonard, reporting
SCHEDULE 13GIntellia Therapeutics, Inc.NTLALIVE Ownership stake disclosure by STATE STREET CORP
STATE STREET CORP, filed by
10-QIntellia Therapeutics, Inc.NTLALIVE 8-KIntellia Therapeutics, Inc.NTLALIVE 4Intellia Therapeutics, Inc.NTLALIVE Edward J Dulac III, insider filing for NTLA
Edward J Dulac III, reporting
4Intellia Therapeutics, Inc.NTLALIVE 2 insider filings
Michael P Dube, insider filing for NTLA
Show all 2
- 4Insider filing for NTLA
- 4Insider filing for NTLA
Michael P Dube, reporting
144Intellia Therapeutics, Inc.NTLALIVE Edward J Dulac III, planned sale of NTLA shares
Edward J Dulac III, reporting
8-KIntellia Therapeutics, Inc.NTLALIVE 4Intellia Therapeutics, Inc.NTLALIVE 7 insider filings
Frank Verwiel, insider filing for NTLA
Show all 7
- 4Insider filing for NTLA
- 4Insider filing for NTLA
- 4Insider filing for NTLA
- 4Insider filing for NTLA
- 4Insider filing for NTLA
- 4Insider filing for NTLA
- 4Insider filing for NTLA
Frank Verwiel, reporting
8-KIntellia Therapeutics, Inc.NTLALIVE 10-QIntellia Therapeutics, Inc.NTLALIVE 8-KIntellia Therapeutics, Inc.NTLALIVE 8-KIntellia Therapeutics, Inc.NTLALIVE ARSIntellia Therapeutics, Inc.NTLALIVE DEFA14AIntellia Therapeutics, Inc.NTLALIVE DEF 14AIntellia Therapeutics, Inc.NTLALIVE SCHEDULE 13GIntellia Therapeutics, Inc.NTLALIVE Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
424B5Intellia Therapeutics, Inc.NTLALIVE SCHEDULE 13GIntellia Therapeutics, Inc.NTLALIVE Ownership stake disclosure by VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC, filed by
424B5Intellia Therapeutics, Inc.NTLALIVE 8-KIntellia Therapeutics, Inc.NTLALIVE 8-KIntellia Therapeutics, Inc.NTLALIVE SCHEDULE 13G/AIntellia Therapeutics, Inc.NTLALIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
4Intellia Therapeutics, Inc.NTLALIVE 6 insider filings
James Basta, insider filing for NTLA
Show all 6
- 4Insider filing for NTLA
- 4Insider filing for NTLA
- 4Insider filing for NTLA
- 4Insider filing for NTLA
- 4Insider filing for NTLA
- 4Insider filing for NTLA
James Basta, reporting
424B5Intellia Therapeutics, Inc.NTLALIVE 8-KIntellia Therapeutics, Inc.NTLALIVE S-8Intellia Therapeutics, Inc.NTLALIVE 10-KIntellia Therapeutics, Inc.NTLALIVE 8-KIntellia Therapeutics, Inc.NTLALIVE SCHEDULE 13G/AIntellia Therapeutics, Inc.NTLALIVE Ownership stake disclosure by GOLDMAN SACHS GROUP INC (amended)
GOLDMAN SACHS GROUP INC, filed by
SCHEDULE 13G/AIntellia Therapeutics, Inc.NTLALIVE Ownership stake disclosure by Contrarius Investment Management Ltd (amended)
Contrarius Investment Management Ltd, filed by
SCHEDULE 13GIntellia Therapeutics, Inc.NTLALIVE Ownership stake disclosure by STATE STREET CORP
STATE STREET CORP, filed by
SCHEDULE 13G/AIntellia Therapeutics, Inc.NTLALIVE Ownership stake disclosure by ARK Investment Management LLC (amended)
ARK Investment Management LLC, filed by